Pharmafile Logo
Pharmafocus logo
Advanced Search

fraud

Showing 15 posts of 15 posts found.

5997920696_ecb224068e_b

CEO of PixarBio Corporation sentenced to prison for defrauding investors

February 19, 2020
Research and Development Biopharmaceuticals, CEO, FDA, corruption, fraud, investors

Frank Reynolds, the CEO of Boston based PixarBio Corporation, was sentenced to seven years in prison for defrauding investors and …

News

Teva settles $135 million dollar fraud case over Medicaid price inflation

January 14, 2019
Sales and Marketing court, fraud, law, lawsuit, pharma, price fxing

Israeli multinational Teva Pharmaceuticals has agreed to pay $135 million after being accused of fraudulently inflating wholesale prices that went …

News
emergency-ambulance-london-vehicle-medical-1665303

Digital system may prevent £300m prescription fraud losses for NHS by 2020

October 15, 2018
Sales and Marketing NHS, fraud, government, prescription fraud, uk politics

The British government are launching a new digitised system aimed at cracking down on prescription fraud in the NHS. However …

News
dubai

Indian biotech owner detained in Dubai over £550m fraud allegations

August 16, 2018
Medical Communications Dubai, Gujurat, India, Sterling Biotech, UAE, fraud

Indian businessman Nitin Sandesara, the owner of the Gujarat-based pharmaceutical company Sterling Biotech, has been detained in Dubai in relation …

News
valeant

Former Valeant executive and Philidor CEO charged with fraud

November 18, 2016
Medical Communications, Sales and Marketing Philidor, Valeant, Valeant Pharmaceuticals, fraud

Gary Tanner, former executive, and Andrew Davenport, ex-CEO of Philidor, have been arrested and charged with fraud. Preet Bharara, US …

News
valeant

Hard times continue for Valeant as ex-CEO investigated for fraud

November 1, 2016
Manufacturing and Production CEO, Valeant, Valeant Pharmaceuticals, accounting, fraud

Valeant Pharmaceuticals continues to have a tough time after Bloomsberg broke the story of how former CEO J. Michael Pearson …

News
gavel

Former shareholders sue Valeant, alleging “vast fraud”

August 19, 2016
Medical Communications, Sales and Marketing Valeant, fraud, lawsuit, t rowe price

Valeant Pharmaceuticals has confirmed that it is being sued by one its former largest shareholders, T Rowe Price, who claim …

News
pfizer_finland_hq

Pfizer to pay $784.6 million fine due to Wyeth Medicaid fraud

April 28, 2016
Medical Communications, Sales and Marketing False Claims Act, Medicaid, Pfizer, US, Wyeth, department, fraud, insurer, justice

Pfizer has agreed to pay $784.6 million in a settlement with the US Department of Justice, relating to false and …

News
Turing logo

Top five pharma controversies of 2015 (so far)

November 20, 2015
Medical Communications, Sales and Marketing AstraZeneca, Martin Shkreli, Philidore, Takeda, Turing Pharmaceutical, Valeant, Warner Chilcott, controversies, fraud, reputation, tax avoidance, turing

5. AstraZeneca forced to deny tax avoidance allegations

Feature
mark_filip

Former Deputy Attorney General called in to advise Valeant after fraud allegations

November 2, 2015
Medical Communications, Sales and Marketing Mark Filip, Philidor, Valeant, fraud

Valeant Pharmaceuticals’ board of directors has appointed former Deputy Attorney General of the United States Mark Filip to advise the …

Appointment
Allergan

Allergan subsidiary president arrested on kickback charges

November 2, 2015
Sales and Marketing Allergan, US District Court, Warner Chilcott, fraud, healthcare fraud

Allergan subsidiary Warner Chilcott will plead guilty to a US felony charge of healthcare fraud, and settle a case of …

News
novartis image

Novartis faces data fraud charges in Japan

July 3, 2014
Medical Communications, Sales and Marketing Diovan, Japan, Novartis, data, fraud, heart, valsartan

Novartis is facing criminal charges in Japan over the alleged falsifying of data for its once big-selling heart drug Diovan. …

News

Novartis back under microscope

June 23, 2014
Medical Communications, Sales and Marketing Italy, Novartis, avastin, fraud, influenza, vaccines

Novartis is under the microscope yet again in Italy, with police visiting the company’s sites at Siena and Origgio in …

News
Advair image

GSK ruling: Another failing, but will the industry learn?

July 4, 2012
Medical Communications, Sales and Marketing GSK, fraud, legal, marketing fine

Court papers surrounding GSK’s $3 billion fraud charge make for grim reading, and further damages an industry that already struggles …

News
The SEC

GSK’s Stiefel accused of shares fraud

December 13, 2011
Sales and Marketing GSK, SEC, Stiefel, fraud

The US financial regulator has charged a subsidiary of GlaxoSmithKline with defrauding staff by buying back shares from them at …

News

Latest content

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023

FDA grants breakthrough device designation to Inflammatix’s TriVerity Acute Infection and Sepsis Test System

November 29, 2023

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023

Arcturus Therapeutics gains FDA ODD for cystic fibrosis treatment

November 28, 2023

Sanofi and Regeneron share results from phase 3 trial for Dupixent as COPD treatment

November 27, 2023